Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer

被引：0
|
作者：
Sridhar, Srikala S. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2019年 / 13卷 / 12期
关键词：
THERAPY;
D O I：
10.5489/cuaj.6346
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 405
页数：2
相关论文
共 50 条
  • [41] Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer
    Sutera, P. A.
    Shetty, A. C.
    Hakansson, A.
    Van der Eecken, K.
    Song, Y.
    Liu, Y.
    Chang, J.
    Fonteyne, V.
    Mendes, A. A.
    Lumen, N.
    Delrue, L.
    Verbeke, S.
    De Man, K.
    Rana, Z.
    Hodges, T.
    Hamid, A.
    Roberts, N.
    Song, D. Y.
    Pienta, K.
    Ross, A. E.
    Feng, F.
    Joniau, S.
    Spratt, D.
    Gillessen, S.
    Attard, G.
    James, N. D.
    Lotan, T.
    Davicioni, E.
    Sweeney, C.
    Tran, P. T.
    Deek, M. P.
    Ost, P.
    ANNALS OF ONCOLOGY, 2023, 34 (07) : 605 - 614
  • [42] Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients
    Pathak, Surabhi
    Thekkekara, Romy
    Yadav, Udit
    Ahmed, Ahmed Tarig
    Yim, Barbara
    Lad, Thomas E.
    Mullane, Michael
    Batra, Kumar Kunnal
    Aronow, Wilbert S.
    Psutka, Sarah P.
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E380 - E387
  • [43] Abiraterone or docetaxel in men with metastatic castration-sensitive prostate cancer: A pooled analysis of castration resistance-free survival and toxicity.
    Helou, Joelle
    Catton, Charles N.
    Bauman, Glenn
    Fazelzad, Rouhi
    Raphael, Jacques
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [44] Phenotypes of circulating tumour cells predict time to castration resistance in metastatic castration-sensitive prostate cancer
    Yang, Yun-Jie
    Kong, Yun-Yi
    Li, Gao-Xiang
    Wang, Yue
    Ye, Ding-Wei
    Dai, Bo
    BJU INTERNATIONAL, 2019, 124 (02) : 258 - 267
  • [45] Novel Treatment Strategies for Low-Risk Metastatic Castration-Sensitive Prostate Cancer
    Iwamoto, Hiroaki
    Hori, Tomohiro
    Nakagawa, Ryunosuke
    Kano, Hiroshi
    Makino, Tomoyuki
    Naito, Renato
    Yaegashi, Hiroshi
    Kawaguchi, Shohei
    Nohara, Takahiro
    Shigehara, Kazuyoshi
    Izumi, Kouji
    Mizokami, Atsushi
    CANCERS, 2024, 16 (18)
  • [46] Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive for Prostate Cancer
    Stopsack, Konrad H.
    Nandakumar, Subhiksha
    Wibmer, Andreas G.
    Haywood, Samuel
    Weg, Emily S.
    Barnett, Ethan S.
    Kim, Chloe J.
    Carbone, Emily A.
    Vasselman, Samantha E.
    Nguyen, Bastien
    Hullings, Melanie A.
    Scher, Howard I.
    Morris, Michael J.
    Solit, David B.
    Schultz, Nikolaus
    Kantoff, Philip W.
    Abida, Wassim
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3230 - 3238
  • [47] Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer
    Isaksson, Jenny
    Green, Henrik
    Papantoniou, Dimitrios
    Pettersson, Linn
    Anden, Mats
    Rosell, Johan
    Avall-Lundqvist, Elisabeth
    Elander, Nils Oskar
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (11): : 1009 - 1022
  • [48] Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer
    Bilgin, Burak
    Sendur, Mehmet A. N.
    Hizal, Mutlu
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    FUTURE ONCOLOGY, 2017, 13 (22) : 1911 - 1913
  • [49] Patient-reported Outcomes in Metastatic Castration-sensitive Prostate Cancer in the Adjuvant Setting
    Morgans, Alicia K.
    Stockler, Martin R.
    EUROPEAN UROLOGY FOCUS, 2019, 5 (02): : 144 - 146
  • [50] Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer
    Fukuokaya, Wataru
    Mori, Keiichiro
    Yanagisawa, Takafumi
    Urabe, Fumihiko
    Rajwa, Pawel
    Briganti, Alberto
    Shariat, Shahrokh F.
    Matsubara, Nobuaki
    Kimura, Takahiro
    Hirakawa, Akihiro
    CANCER, 2025, 131 (07)
12345